Navigation Links
CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Date:3/11/2009

and/or remove certain viruses during manufacturing. Despite these measures, such products may still potentially transmit disease. There is also the possibility that unknown infectious agents may be present in such products.

The most serious adverse reactions that have been reported in clinical studies or through postmarketing surveillance following RiaSTAP treatment are allergic-anaphylactic reactions and thromboembolic episodes, including myocardial infarction, pulmonary embolism, deep vein thrombosis and arterial thrombosis. The most common adverse reactions that have been reported in clinical studies or through postmarketing surveillance following RiaSTAP treatment are allergic reactions and generalized reactions such as chills, fever, nausea and vomiting.

For more information, visit www.riastap.com.

About CSL Behring

CSL Behring is a global leader in the plasma protein biotherapeutics industry. Passionate about improving the quality of patients' lives, CSL Behring manufactures and markets a range of safe and effective plasma-derived and recombinant products and related services. The company's therapies are used in the treatment of immune deficiency disorders, hemophilia, von Willebrand disease, other bleeding disorders and inherited emphysema. Other products are used for the prevention of hemolytic diseases in the newborn, in cardiac surgery, organ transplantation and in the treatment of burns. The company also operates one of the world's largest plasma collection networks, ZLB Plasma. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company with headquarters in Melbourne, Australia. For more information, visit www.cslbehring.com. 

    Contact:
    Sheila A. Burke, Director, Communications & Public Relations
    W
'/>"/>
SOURCE  CSL Behring
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 

Related medicine technology :

1. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
2. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
3. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
4. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
5. Childrens Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia
6. deCODE Receives California Clinical Laboratory License
7. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
8. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
9. PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications
10. Kiadis Pharma Receives Two Orphan Drug Designations for Reviroc(TM) From the FDA
11. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... -- Royal Philips (NYSE: PHG, AEX: PHIA) ... in Imaging Equipment in the 2013 Best in KLAS ... Best in KLAS and Best in Category awards for ... Computed Tomography (CT), Ingenia 1.5T and 3.0T Magnetic Resonance ... Best in KLAS Awards: Medical Imaging & Infrastructure are ...
(Date:6/18/2013)... YORK, Pa. , June 18, 2013 ... a U.S. based designer, developer and manufacturer of injectable ... new corporate website at www.unilife.com . The new ... information, with updates to occur on a regular basis. ... of Unilife, stated, "As an emerging global leader for ...
(Date:6/18/2013)... Calif. , June 18, 2013  Women are ... families, but unfortunately they often do not give the ... women have kept information from their doctor because they ... it, according to a recent survey conducted by Allergan ... organization dedicated to bringing education, funding and research to ...
Breaking Medicine Technology:Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2Unilife Launches New Corporate Website 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 3New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 4New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 5New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 6New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 7New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 8New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 9
... Dec. 10 The US Food and,Drug Administration ... small,open, long-term, clinical studies in patients with gastro-esophageal ... study) or NEXIUM(R) (LOTUS study) treatment., AstraZeneca ... conclusion which states,"FDA continues to conclude that long-term ...
... 3 Results Released at American Society of Hematology ... Genta,Incorporated (Nasdaq: GNTA ) announced the release ... patients in the Company,s randomized Phase,3 trial of ... lymphocytic leukemia (CLL). The new data show that,patients ...
Cached Medicine Technology:FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 2FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 3FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 2Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 3Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 4Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 5Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission 6
(Date:6/18/2013)... Lesbian, Gay, Bisexual and Transgender (LGBT) Pride ... sexual minority youth are still at greater ... according to the Suicide Prevention Resource Center. ... recently published recommendation to improve psychologists, treatment ... improve psychological functioning and reduce depression and ...
(Date:6/18/2013)... 2013)-- An international team of investigators co-led by Weill ... evidence-based surgery and device research, similar to the kind ... , "Currently, there is no dynamic research framework to ... benefits to patients or may even be harmful," says ... College. , In the June 18 issue of ...
(Date:6/18/2013)... FL (PRWEB) June 18, 2013 There ... best education for students around the country. Some of ... life is enriched by the areas or region. The ... the benefits of attending one of these hidden gems ... show informs viewers of the educational facilities with better ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Dr. Farooq ... the Atlanta Vision Institute, is pleased to announce that ... generation of Intralase LASIK equipment, the iFS™ Advanced Femtosecond ... LASIK practice in Atlanta to offer its patients this ... is giving his patients a complimentary upgrade to the ...
(Date:6/18/2013)... New York, NY (PRWEB) June 18, 2013 ... to protecting the rights of consumers, has filed a ... central air conditioner units from 2007 and onward under ... evaporator coils . The lawsuit was filed on May ... District of Florida (Case No. 8:13-cv-1213T17TBM). Goodman Global Inc., ...
Breaking Medicine News(10 mins):Health News:Sexual minority youth need specialized treatment from therapists 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3Health News:Editions TV Presents a Segment on the Higher Education Hidden Gems 2Health News:Atlanta LASIK Surgeon Offers New LASIK Technology 2Health News:Goodman and Amana Air Conditioners Allegedly Violated Consumer Warranties, Charges Class Action Lawsuit Filed by Parker Waichman LLP 2
... Their own funds for the treatment of their thalassaemic daughter ... braving the odds to spread awareness about the disease.// ... district. Before tying the knot, they didn't know how thalassaemia ... the importance of a premarital blood detection test and initiated ...
... Lebanon, a Mediterranean country, is considered notoriously image-conscious. It may ... militants// clashing fiercely all the time. ,But the ... ,Only that should explain why the Fist National Bank ... surgery. ,Its website dubs the 'plastic surgery loans' ...
... [CNS] in animal evolution has puzzled scientists for centuries. ... but their CNSs are different and were thought to ... evolution. Researchers from the European Molecular Biology Laboratory [EMBL] ... is probably much older than expected. The study, which ...
... Thomas Jefferson University Hospital are combining efforts to determine if ... forms of migraine headaches. ,Investigators from the Jefferson ... in a blinded study to determine if closing a Patent ... allow blood to flow between the right and left sides ...
... up its socks on health issues, lest it pay a ... diseases’. If the present trend continues//, 66% of deaths by ... ,A study conducted by Assocham and Price Waterhouse Coopers (PwC) ... vulnerability of the Indian population to cardiovascular disease. It is ...
... foods and toys it is the turn of beef products ... following fears of E coli outbreak. Four of the five ... ,E. coli, or Escherichia coli, is a common ... cramps, fever, bloody diarrhea, kidney failure, blindness, paralysis and sometimes ...
Cached Medicine News:Health News:Thalassaemic Child's Parents Campaign for Awareness 2Health News:Loans for Cosmetic Surgery in Lebanon 2Health News:The Origin of the Brain Lies in a Worm 2Health News:Jefferson Researchers Want to Learn If Heart Defect 'at Heart' of Some Migraines 2Health News:E Coli Outbreak Forces Large-scale Recall of Beef Products 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: